We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+12.96%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$3.89B
AUM Growth
+$125M
Cap. Flow
-$226M
Cap. Flow %
-5.82%
Top 10 Hldgs %
15.92%
Holding
230
New
17
Increased
95
Reduced
68
Closed
21

Sector Composition

Rank Sector Weight
1 Technology 25.66%
2 Consumer Discretionary 15.66%
3 Healthcare 15.51%
4 Industrials 11.08%
5 Communication Services 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RKUS
26
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
$36.9M 0.95%
2,598,750
+208,600
+9% +$3.07M
NKTR icon
27
Nektar Therapeutics
NKTR
$2.58B
$36.6M 0.94%
215,194
+34,205
+19% +$5.52M
GES
28
DELISTED
Guess Inc
GES
$36.6M 0.94%
1,176,965
XRAY icon
29
Dentsply Sirona
XRAY
$2.43B
$36M 0.93%
743,250
+182,900
+33% +$8.56M
PSIX
30
Power Solutions International
PSIX
$942M
$35.6M 0.91%
473,819
+27,241
+6% +$1.79M
TIVO
31
DELISTED
TIVO INC
TIVO
$35.1M 0.9%
2,678,320
-57,400
-2% -$743K
MATV icon
32
Mativ Holdings
MATV
$711M
$34.6M 0.89%
672,400
-13,600
-2% -$752K
IMAX icon
33
IMAX
IMAX
$2.66B
$34M 0.87%
1,152,851
+93,311
+9% +$2.68M
DECK icon
34
Deckers Outdoor
DECK
$13.3B
$33.8M 0.87%
+2,399,400
New +$29.6M
OMG
35
DELISTED
OM GROUP INC.
OMG
$33.7M 0.87%
926,891
+205,841
+29% +$6.89M
MINI
36
DELISTED
Mobile Mini Inc
MINI
$33.3M 0.86%
809,300
-250,000
-24% -$9.31M
BIO icon
37
Bio-Rad Laboratories Class A
BIO
$9.42B
$32.9M 0.85%
266,134
SMCI icon
38
Super Micro Computer
SMCI
$20.1B
$32.7M 0.84%
19,045,570
+660,160
+4% +$997K
RVBD
39
DELISTED
RIVERBED TECHNOLOGY, INC COM
RVBD
$31.3M 0.8%
1,730,400
+31,700
+2% +$513K
DBI icon
40
Designer Brands
DBI
$333M
$31.3M 0.8%
731,800
-200,000
-21% -$8.67M
SPSC icon
41
SPS Commerce
SPSC
$2.64B
$31.1M 0.8%
952,662
-129,170
-12% -$4.39M
AZPN
42
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$31.1M 0.8%
744,098
+219,068
+42% +$9.16M
TER icon
43
Teradyne
TER
$59.3B
$30.3M 0.78%
1,718,680
-93,300
-5% -$1.58M
STAG icon
44
STAG Industrial
STAG
$7.19B
$30M 0.77%
1,473,093
+466,343
+46% +$9.72M
ZLTQ
45
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$29.8M 0.77%
1,577,024
+564,707
+56% +$8.07M
INVN
46
DELISTED
Invensense Inc
INVN
$29.1M 0.75%
1,399,400
+232,500
+20% +$4.16M
VRTX icon
47
Vertex Pharmaceuticals
VRTX
$126B
$28.8M 0.74%
388,100
AWAY
48
DELISTED
HOMEAWAY INC COM
AWAY
$28.7M 0.74%
703,010
+262,682
+60% +$8.95M
KAMN
49
DELISTED
Kaman Corp
KAMN
$28.6M 0.74%
720,968
+31,348
+5% +$1.2M
GWR
50
DELISTED
Genesee & Wyoming Inc.
GWR
$28.4M 0.73%
295,260
+9,700
+3% +$935K

Similar funds

Granahan Investment Management's Q4 2013 Portfolio in Review

As of Q4 2013, Granahan Investment Management held 230 positions worth $3.89B, up 3.3% from $3.76B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Granahan Investment Management withdrew a net $226M in Q4 2013, closing 21 positions and reducing 68 holdings. Its most notable exit was BioMarin Pharmaceuticals, an estimated $40.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Granahan Investment Management opened a new position in Deckers Outdoor worth $33.8M.

  • Granahan Investment Management's largest Q4 2013 buy was Deckers Outdoor: 2,399,400 shares worth $33.8M.
  • Granahan Investment Management added most to A T M I INC in Q4 2013, an estimated $32.5M increase.
  • Granahan Investment Management's biggest Q4 2013 reduction was Sotheby's, cutting an estimated $27.7M.
  • Granahan Investment Management fully exited BioMarin Pharmaceuticals in Q4 2013, selling an estimated $40.1M.
  • Granahan Investment Management's ten largest holdings make up 16% of its $3.89B portfolio in Q4 2013.
  • Granahan Investment Management opened 17 new positions and closed 21 in Q4 2013.
  • Granahan Investment Management's portfolio value rose 3.3% quarter-over-quarter to $3.89B.

Based on Granahan Investment Management's 13F filing for Q4 2013, filed 30 Jan 2014.